PPAP2024-04-012024-06-30 PPAP2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member PPAP2024-06-30 PPAP2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532934 PPAP NOTLISTED PPAP Automotive Limited Equity 2024-04-01 2025-03-31 2024-08-10 2024-08-05 INR Lakhs First quarter 11:45:00 15:45:00 2024-08-10 2024-08-10 Not applicable Single segment Manufacturing of automotive components 2024-04-01 2024-06-30 Unaudited Standalone 1186778000.00 12848000.00 1199626000.00 681992000.00 0.00 -10644000.00 228009000.00 32976000.00 80812000.00 167655000.00 1180800000.00 18826000.00 0.00 18826000.00 3375000.00 1250000.00 4625000.00 0.00 14201000.00 0.00 0.00 0.00 0.00 14201000.00 -4201000.00 10000000.00 0.00 0.00 140865000.00 10 1.01 1.01 0.00 0.00 1.01 1.01 Notes to Statement of Unaudited Standalone Financial Results for the quarter ended 30th June, 2024: 1. The above financial results have been prepared in accordance with Indian Accounting Standards ( Ind AS ) notified under Section 133 of the Companies Act, 2013, read together with the Companies (Indian Accounting Standards) Rules, 2015 (as amended). 2. The above financial results have been reviewed by the Audit Committee in its meeting held on 10th August, 2024 and then approved by the Board of Directors in its meeting held on 10th August, 2024. The limited review, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 has been completed by the Statutory Auditors for the quarter ended 30th June, 2024 and they have expressed an unmodified opinion on the aforesaid results. 3. The Company is primarily engaged in the business of manufacturing of automotive components, development and sale of plastic injection molds and development and sale of components for consumer goods. The company operates only in one reportable segment i.e. automotive component as per Ind AS 108 (Operating Segment) and hence no separate disclosure is required for segments. 4. During the quarter, the Company has allotted 86,513 shares upon exercise of stock options by ESOP holders under PPAP Employee Stock Option Plan 2022. 5. The figures of quarter ended 31st March, 2024 are the balancing figures between the audited figures in respect of full financial year and the published figures of nine months ended 31st December, 2023 respectively, which were subject to limited review by the Statutory Auditors. Other expenses 167655000.00 Gain/(loss) on defined benefit obligation -2243000.00 -2243000.00 1958000.00 0.00